X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
male (44) 44
middle aged (43) 43
female (41) 41
aged (37) 37
peripheral vascular disease (25) 25
cardiac & cardiovascular systems (21) 21
adult (19) 19
thrombolytic therapy (19) 19
treatment outcome (16) 16
pulmonary embolism - drug therapy (13) 13
recurrence (13) 13
medicine, general & internal (12) 12
pulmonary embolism (12) 12
risk factors (12) 12
aged, 80 and over (11) 11
prognosis (11) 11
prospective studies (11) 11
double-blind method (10) 10
myocardial infarction - therapy (10) 10
pulmonary embolism - diagnostic imaging (10) 10
time factors (9) 9
index medicus (8) 8
myocardial infarction - drug therapy (8) 8
myocardial infarction - mortality (8) 8
thrombolysis (8) 8
anticoagulants - therapeutic use (7) 7
echocardiography (7) 7
follow-up studies (7) 7
heparin (7) 7
pulmonary embolism - diagnosis (7) 7
pulmonary embolism - physiopathology (7) 7
radiography (7) 7
retrospective studies (7) 7
angioplasty, balloon, coronary (6) 6
fibrinolytic agents - therapeutic use (6) 6
gene therapy (6) 6
heparin - therapeutic use (6) 6
trial (6) 6
acute disease (5) 5
adeno-associated virus (5) 5
age factors (5) 5
alteplase (5) 5
balloon angioplasty (5) 5
coronary angiography (5) 5
drug therapy (5) 5
drug therapy, combination (5) 5
echocardiography, transesophageal (5) 5
hemodynamics - drug effects (5) 5
management (5) 5
metaanalysis (5) 5
myocardial infarction - physiopathology (5) 5
myocardial-infarction (5) 5
plasminogen-activator (5) 5
pulmonary embolism - etiology (5) 5
radionuclide imaging (5) 5
respiratory system (5) 5
risk (5) 5
tissue plasminogen activator - therapeutic use (5) 5
aav (4) 4
angioplasty, balloon, coronary - adverse effects (4) 4
anistreplase (4) 4
biotechnology & applied microbiology (4) 4
cardiovascular system (4) 4
genetics & heredity (4) 4
hematology (4) 4
hemorrhage - chemically induced (4) 4
heparin - adverse effects (4) 4
heparin, low-molecular-weight - therapeutic use (4) 4
hospital mortality (4) 4
infusions, intravenous (4) 4
life sciences (4) 4
logistic models (4) 4
medicine, research & experimental (4) 4
pulmonary artery - diagnostic imaging (4) 4
pulmonary embolism - complications (4) 4
right ventricular dysfunction (4) 4
streptokinase (4) 4
therapy (4) 4
thrombolytic therapy - adverse effects (4) 4
thrombosis - complications (4) 4
urokinase (4) 4
[ sdv ] life sciences [q-bio] (3) 3
abridged index medicus (3) 3
abstracts (3) 3
acute myocardial infarction (3) 3
angina, unstable - drug therapy (3) 3
angioplasty (3) 3
artery disease (3) 3
care and treatment (3) 3
cohort studies (3) 3
drug administration schedule (3) 3
electrocardiography (3) 3
evaluation (3) 3
exercise test (3) 3
experience (3) 3
fibrinolytic agents - adverse effects (3) 3
follow-up (3) 3
gastric acidity determination (3) 3
gene transfer (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 15, pp. 1402 - 1411
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 03/2015, Issue 206-207, pp. 138 - 155
Passed in 2009, the HADOPI law has created a system of sanctions directed against the illegal downloading of cultural goods. Directors belonging to several... 
Journal Article
ACTES DE LA RECHERCHE EN SCIENCES SOCIALES, ISSN 0335-5322, 03/2015, Issue 206, pp. 138 - 155
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, pp. 138 - 155
Adoptée en 2009, la loi HADOPI a mis en place un dispositif de sanction des pratiques de téléchargement illégal de biens culturels. À travers des pétitions,... 
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Issue 206-207, pp. 138 - 155
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, p. 138
Journal Article
Human Gene Therapy, ISSN 1043-0342, 07/2018, Volume 29, Issue 7, pp. 771 - 784
Journal Article
Molecular Therapy, ISSN 1525-0016, 06/2017, Volume 25, Issue 6, pp. 1375 - 1386
Journal Article
Chest, ISSN 0012-3692, 2001, Volume 120, Issue 1, pp. 120 - 125
Study objectives: To assess the potential benefit of thrombolysis in patients with massive pulmonary embolism (PE) with stable hemodynamics and right... 
Massive pulmonary embolism | Heparin | Low-molecular-weight heparin | Thrombolysis | Right ventricular dysfunction | CARDIAC & CARDIOVASCULAR SYSTEMS | massive pulmonary embolism | MYOCARDIAL-INFARCTION | ECHOCARDIOGRAPHIC EVALUATION | MULTICENTER REGISTRY | DOPPLER | INTRACRANIAL HEMORRHAGE | RANDOMIZED TRIAL | heparin | PLASMINOGEN-ACTIVATOR | SARUPLASE | RESPIRATORY SYSTEM | thrombolysis | MOLECULAR-WEIGHT HEPARINS | low-molecular-weight heparin | right ventricular dysfunction | UNFRACTIONATED HEPARIN | Recurrence | Humans | Heparin - therapeutic use | Male | Lung - diagnostic imaging | Pulmonary Artery - diagnostic imaging | Heparin - adverse effects | Fibrinolytic Agents - adverse effects | Dilatation | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Ventilation-Perfusion Ratio | Female | Retrospective Studies | Heart Ventricles - pathology | Pulmonary Embolism - complications | Echocardiography | Radiography | Pulmonary Embolism - diagnosis | Radionuclide Imaging | Ventricular Dysfunction, Right - complications | Plasminogen Activators - therapeutic use | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Ventricular Dysfunction, Right - pathology | Cohort Studies | Plasminogen Activators - adverse effects | Pulmonary Embolism - physiopathology | Ventricular Dysfunction, Right - diagnostic imaging | Pulmonary embolism | Evaluation | Care and treatment | Thrombolytic therapy
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 8, pp. 1326 - 1334
Journal Article
Cell Reports, ISSN 2211-1247, 05/2018, Volume 23, Issue 6, pp. 1817 - 1830
The adeno-associated virus (AAV) vector is a preferred delivery platform for in vivo gene therapy. Natural and engineered variations of the AAV capsid affect a... 
AAP | AAV | capsid | capsid assembly | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | ADENOASSOCIATED VIRUS TYPE-2 | TRANSDUCTION EFFICIENCY | MOTIFS | SEROTYPE 9 | IN-VITRO | INFECTIVITY | IMPROVES | IDENTIFICATION | GENE-THERAPY VECTOR | INTRACELLULAR TRAFFICKING | CELL BIOLOGY
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1
Journal Article
Cell Reports, ISSN 2211-1247, 05/2018, Volume 23, Issue 6, pp. 1817 - 1830
The adeno-associated virus (AAV) vector is a preferred delivery platform for gene therapy. Natural and engineered variations of the AAV capsid affect a... 
AAP | AAV | capsid assembly | capsid | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | Life Sciences | Human health and pathology
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Issue 206-207, pp. 4 - 13
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, pp. 4 - 13
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.